Hematological Malignancies
RICOVER-60-no-RT
per protocol Analysis
25% difference
PFS
OS
EFS
90% [95%-CI: 84-97]
88% [95%-CI: 80-95 ]
80% [95%CI: 71-89 ]
65% [95%-CI: 49-81 ]
62% [95%-CI: 46-78 ]
54% [95%-CI: 38-71 ]
p=0.001
p=0.001
p<0.001
months
(n=78)
RICOVER-60
RICOVER-60-no-RX
(n=35)
Held , JCO 2014
Made with FlippingBook